Impact of Diabetes on Five-Year Outcomes of Patients With Multivessel Coronary Artery Disease Whady Hueb, MD, Bernard J. Gersh, MB, ChB, Fernando Costa,

Slides:

Advertisements

Similar presentations

Ten-Year Follow-up Survival of the Medicine, Angioplasty, or Surgery Study (MASS-II): a Randomized Controlled Clinical Trial of Therapeutic Strategies.

Advertisements

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Impact of Chronic Kidney Disease on Long-Term Outcomes in Type 2 Diabetic Patients With Coronary Artery Disease on Surgical, Angioplasty, or Medical Treatment

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,

Coronary Artery Bypass for Heart Failure in Ischemic Cardiomyopathy: 17-Year Follow- Up Marco Pocar, MD, PhD, Andrea Moneta, MD, Adalberto Grossi, MD,

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Long-Term Outcome of Coronary Artery Bypass Grafting in Patients With Left Ventricular Dysfunction Paolo Nardi, MD, PhD, Antonio Pellegrino, MD, Antonio.

Similar Outcome in Insulin-Dependent and Noninsulin-Dependent Diabetic Patients After Off-Pump Coronary Artery Bypass Grafting With Multiple Skeletonized.

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Metabolic Syndrome Affects Midterm Outcome After Coronary Artery Bypass Grafting Emiliano Angeloni, MD, Giovanni Melina, PhD, Umberto Benedetto, PhD,

Preoperative Aspirin Use and Its Effect on Adverse Events in Patients Undergoing Cardiac Operations Jiapeng Huang, MD, PhD, Macarius Donneyong, PhD,

Revascularization of Left Anterior Descending Artery With Drug-Eluting Stents: Comparison With Off-Pump Surgery Itzhak Herz, MD, Yaron Moshkovitz, MD,

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Off-pump Bilateral Skeletonized Internal Thoracic Artery Grafting in Elderly Patients Takeshi Kinoshita, MD, Tohru Asai, MD, PhD, Tomoaki Suzuki, MD,

Peter K. Smith, MD The Annals of Thoracic Surgery

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Does Diabetes Affect the Postoperative Outcomes After Total Arterial Off-Pump Coronary Bypass Surgery in Multivessel Disease? Jae-Sung Choi, MD, PhD,

Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention? Serenella Castelvecchio,

The Impact of Peripheral Vascular Disease on Long-Term Survival After Coronary Artery Bypass Graft Surgery Danny Chu, MD, Faisal G. Bakaeen, MD, Xing.

Results of Low-Dose Carperitide Infusion in High-Risk Patients Undergoing Coronary Artery Bypass Grafting Akira Sezai, MD, PhD, Kin-ichi Nakata, MD,

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,

n-3 Polyunsaturated Fatty Acids After Coronary Artery Bypass Grafting

The Society of Thoracic Surgeons Thoracic Surgery Practice and Access Task Force: 2014 Workforce Report John S. Ikonomidis, MD, PhD The Annals of Thoracic.

Accuracy of Myocardial Biomarkers in the Diagnosis of Myocardial Infarction After Revascularization as Assessed by Cardiac Resonance: The Medicine, Angioplasty,

Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease Daniel Wendt, MD, Philipp Kahlert, MD, Tim Lenze, Markus Neuhäuser,

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Off-Pump Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention: A Meta-Analysis of Randomized and Nonrandomized Studies J. James Edelman,

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

Influence of Diabetes Mellitus on Long-Term Clinical and Economic Outcomes After Coronary Artery Bypass Grafting Heng Zhang, MD, Xin Yuan, MD, PhD, Ruben.

Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients David C. Chang, PhD,

Coronary Revascularization in Patients With Liver Cirrhosis

Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E

Percutaneous Intervention Before Coronary Artery Bypass Surgery Does Not Unfavorably Impact Survival: A Single-Center Propensity-Matched Analysis Suvitesh.

Improved Outcomes of Total Arterial Myocardial Revascularization in Elderly Patients at Long-Term Follow-Up: A Propensity-Matched Analysis Gianluigi.

Long-Term Survival After Coronary Arterial Grafts in Patients With End-Stage Renal Disease Taro Nakatsu, MD, Nobushige Tamura, MD, PhD, Yutaka Sakakibara,

Bartosz Rylski, MD, Nimesh D. Desai, MD, PhD, Joseph E

Aortic Valve Replacement and Concomitant Coronary Artery Bypass: Assessing the Impact of Multiple Grafts Kimiyoshi J. Kobayashi, BS, Jason A. Williams,

Predictors for Early and Late Outcomes After Coronary Artery Bypass Grafting in Hemodialysis Patients Yoshiyuki Takami, MD, Kazuyoshi Tajima, MD, Wataru.

Long Segmental Reconstruction of Diffusely Diseased Left Anterior Descending Coronary Artery With Left Internal Thoracic Artery With or Without Endarterectomy

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

A. Laurie W. Shroyer, PhD, MSHA, Jacquelyn A. Quin, MD, MPH, Todd H

Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease Neuza Helena Lopes, MD, PhD, Felipe da Silva Paulitsch, MD,

Influence of Diabetes Mellitus on Long-Term Survival in Systematic Off-Pump Coronary Artery Bypass Surgery Bertrand Marcheix, MD, Frédéric Vanden Eynden,

Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Patients with Diabetes Mellitus Yanai Ben-Gal, MD, Yaron Moshkovitz, MD, Nachum Nesher,

Revascularization Strategies and Survival in Patients With Multivessel Coronary Artery Disease Noam Fink, MD, Eugenia Nikolsky, MD, Abid Assali, MD,

One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: A.

Editorial Board, January 2010

Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,

Statin in Combination With β-Blocker Therapy Reduces Postoperative Stroke After Coronary Artery Bypass Graft Surgery Denis Bouchard, MD, Michel Carrier,

Early and Midterm Results of Off-Pump Coronary Artery Bypass Grafting

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

On-Pump Versus Off-Pump Surgical Revascularization for Left Main Stem Stenosis: Risk Adjusted Outcomes John C.Y. Lu, Antony D. Grayson, BS, D. Mark Pullan

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Sequential In Situ Left Internal Thoracic Artery Grafting to the Circumflex and Right Coronary Artery Areas Cihat Bakay, MD, Burak Onan, MD, Aşkin Ali.

Lung Transplantation and Coronary Artery Disease

Reoperation for Coronary Artery Bypass Grafting Surgery: Outcomes and Considerations for Expanding Interventional Procedures Simon Maltais, MD, PhD,

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

The Impact of New Technology on Cardiothoracic Surgical Practice

Off-Pump, In Situ Internal Thoracic Artery Grafting: A Durable Treatment for Single- Vessel Coronary Artery Disease Kerem M. Vural, MD, Zafer H. Iscan,

Previous Percutaneous Coronary Interventions Increase Mortality and Morbidity After Coronary Surgery Vito Mannacio, MD, Luigi Di Tommaso, MD, Vincenzo.

Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J

Presentation transcript:

Impact of Diabetes on Five-Year Outcomes of Patients With Multivessel Coronary Artery Disease Whady Hueb, MD, Bernard J. Gersh, MB, ChB, Fernando Costa, MD, Neuza Lopes, MD, Paulo R. Soares, MD, Paulo Dutra, MD, Fabio Jatene, MD, Alexandre C. Pereira, MD, Aécio F.T. Góis, MD, Sergio A. Oliveira, MD, José A.F. Ramires, MD The Annals of Thoracic Surgery Volume 83, Issue 1, Pages 93-99 (January 2007) DOI: 10.1016/j.athoracsur.2006.08.050 Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Probability of survival free of cardiac-related death for diabetic and nondiabetic patients. (DM = diabetes mellitus; NDM = without diabetes mellitus; Yr = year.) The Annals of Thoracic Surgery 2007 83, 93-99DOI: (10.1016/j.athoracsur.2006.08.050) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Probability of event-free survival for diabetic and nondiabetic patients. (DM = diabetes mellitus; NDM = without diabetes mellitus; Yr = year.) The Annals of Thoracic Surgery 2007 83, 93-99DOI: (10.1016/j.athoracsur.2006.08.050) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Probability of survival free of cardiac-related death among diabetic patients in three treatment groups: medical therapy (MT), coronary artery bypass grafting (CABG), and percutaneous coronary intervention (PCI). (Yr = year.) The Annals of Thoracic Surgery 2007 83, 93-99DOI: (10.1016/j.athoracsur.2006.08.050) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Probability of event-free survival among diabetic patients in three treatment groups: medical therapy (MT), coronary artery bypass grafting (CABG), and percutaneous coronary intervention (PCI). (Yr = year.) The Annals of Thoracic Surgery 2007 83, 93-99DOI: (10.1016/j.athoracsur.2006.08.050) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions